Anixa Biosciences Inc. (ANIX)
Anixa Biosciences Statistics
Share Statistics
Anixa Biosciences has 32.2M shares outstanding. The number of shares has increased by 0.88% in one year.
| Shares Outstanding | 32.2M |
| Shares Change (YoY) | 0.88% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 17.48% |
| Shares Floating | 30.49M |
| Failed to Deliver (FTD) Shares | 3.52K |
| FTD / Avg. Volume | 2.82% |
Short Selling Information
The latest short interest is 322.88K, so 1% of the outstanding shares have been sold short.
| Short Interest | 322.88K |
| Short % of Shares Out | 1% |
| Short % of Float | 1.06% |
| Short Ratio (days to cover) | 3.17 |
Valuation Ratios
The PE ratio is -8.89 and the forward PE ratio is -7.78. Anixa Biosciences's PEG ratio is -0.41.
| PE Ratio | -8.89 |
| Forward PE | -7.78 |
| PS Ratio | 0 |
| Forward PS | 4.5 |
| PB Ratio | 5.58 |
| P/FCF Ratio | -15.22 |
| PEG Ratio | -0.41 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Anixa Biosciences Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.54, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.54 |
| Quick Ratio | 8.54 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 1.15 |
| Cash Flow / Debt | -31.62 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.63% and return on capital (ROIC) is -72.34%.
| Return on Equity (ROE) | -0.63% |
| Return on Assets (ROA) | -0.58% |
| Return on Capital (ROIC) | -72.34% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-2,510,800 |
| Employee Count | 5 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -10.26% in the last 52 weeks. The beta is 0.93, so Anixa Biosciences's price volatility has been higher than the market average.
| Beta | 0.93 |
| 52-Week Price Change | -10.26% |
| 50-Day Moving Average | 2.76 |
| 200-Day Moving Average | 2.95 |
| Relative Strength Index (RSI) | 56.95 |
| Average Volume (20 Days) | 124.81K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -13.83M |
| Net Income | -12.55M |
| EBITDA | -13.83M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.39 |
Balance Sheet
The company has 1.27M in cash and 232K in debt, giving a net cash position of 1.04M.
| Cash & Cash Equivalents | 1.27M |
| Total Debt | 232K |
| Net Cash | 1.04M |
| Retained Earnings | -240.75M |
| Total Assets | 21.59M |
| Working Capital | 18.86M |
Cash Flow
In the last 12 months, operating cash flow was -7.33M and capital expenditures 0, giving a free cash flow of -7.33M.
| Operating Cash Flow | -7.33M |
| Capital Expenditures | 0 |
| Free Cash Flow | -7.33M |
| FCF Per Share | -0.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -12.38% |
| FCF Yield | -7.23% |
Analyst Forecast
The average price target for ANIX is $10, which is 217.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 217.5% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Jun 26, 2015. It was a backward split with a ratio of 1:25.
| Last Split Date | Jun 26, 2015 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | 4.47 |
| Piotroski F-Score | 1 |